(19)
(11) EP 2 943 186 A1

(12)

(43) Date of publication:
18.11.2015 Bulletin 2015/47

(21) Application number: 14702134.9

(22) Date of filing: 09.01.2014
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
A61K 31/5513(2006.01)
(86) International application number:
PCT/US2014/010863
(87) International publication number:
WO 2014/110248 (17.07.2014 Gazette 2014/29)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 09.01.2013 US 201361750792 P
08.02.2013 US 201361762836 P

(71) Applicant: Edgemont Pharmaceuticals LLC
Austin, Texas 78746 (US)

(72) Inventors:
  • SALTEL, Douglas A.
    Austin, Texas 78746 (US)
  • VACHON, Michael
    Austin, Texas 78746 (US)

(74) Representative: Pohlman, Sandra M. 
df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16
80333 München
80333 München (DE)

   


(54) CONTROLLED RELEASE FORMULATIONS OF LORAZEPAM